Enhanced Bioavailability (EAB):

CPI has developed micro particulate technology for poorly soluble drugs for enhanced drug release and absorption.

Advantages

EAB-CAP technologies accelerate drug absorption resulting in faster onset of drug action, lowers dosage levels, enhanced product performance, better indications and extended patent life. Capricorn has developed unique processes for high shear mixing, melt processing, solidification in either crystalline or amorphous form. Nano-crystal growth in high shear mix/melt environment is created.